BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE and DRUG WITHDRAWAL SYNDROME NEONATAL

Overview

DRUG WITHDRAWAL SYNDROME NEONATAL is the #19 most commonly reported adverse reaction for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, manufactured by INDIVIOR INC.. There are 902 FDA adverse event reports linking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE to DRUG WITHDRAWAL SYNDROME NEONATAL. This represents approximately 1.5% of all 59,605 adverse event reports for this drug.

Patients taking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE who experience drug withdrawal syndrome neonatal should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG WITHDRAWAL SYNDROME NEONATAL is a less commonly reported adverse event for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

In addition to drug withdrawal syndrome neonatal, the following adverse reactions have been reported for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE:

• DRUG DEPENDENCE — 4,275 reports
• DRUG WITHDRAWAL SYNDROME — 3,327 reports
• PAIN — 2,543 reports
• OFF LABEL USE — 2,061 reports
• OVERDOSE — 1,850 reports
• NAUSEA — 1,627 reports
• EMOTIONAL DISTRESS — 1,472 reports
• ANXIETY — 1,348 reports
• VOMITING — 1,336 reports
• HEADACHE — 1,109 reports

Other Drugs Associated with DRUG WITHDRAWAL SYNDROME NEONATAL

The following drugs have also been linked to drug withdrawal syndrome neonatal in FDA adverse event reports:

Does BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE cause DRUG WITHDRAWAL SYNDROME NEONATAL?

DRUG WITHDRAWAL SYNDROME NEONATAL has been reported as an adverse event in 902 FDA reports for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG WITHDRAWAL SYNDROME NEONATAL with BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE?

DRUG WITHDRAWAL SYNDROME NEONATAL accounts for approximately 1.5% of all adverse event reports for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, making it a notable side effect.

What should I do if I experience DRUG WITHDRAWAL SYNDROME NEONATAL while taking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE?

If you experience drug withdrawal syndrome neonatal while taking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages